Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
252.50    2.50 (1.00%)
Bid:
250.00
Ask:
255.00
Spread: 5.00 (2.00%)
Market Cap: £229.38m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Trading Update

Today 07:00

RNS Number : 9762L
Concurrent Technologies PLC
13 July 2026
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

 

13 July 2026

Concurrent Technologies Plc

("Concurrent", the "Company" or the "Group")

 

Trading Update

 

Record H1 performance and strong order momentum

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems and mission critical solutions used in high-performance markets by some of the world's major OEMs, provides an update on trading for the six months to 30 June 2026 ("H1 FY26").

 

Based on its unaudited management accounts for H1 FY26, the Company expects to report record results for a first half, with revenue of approximately £23.1m (H1 FY25: £21.1m) and profit before tax of approximately £3.3m (H1 FY25: £2.7m).

 

Order intake for H1 FY26 was significantly ahead of the prior year at £46.9m, up 110% (H1 FY25 £22.3m), driven by demand across the Group's key geographies and end markets. This included the c.£17m multi-year order secured from a European customer announced in June 2026. Excluding this order, the Group nevertheless achieved record order intake compared to any prior half-year period.

 

The Systems business secured approximately $8m of orders during the period and delivered a profitable first half. The business continues to make progress and is expected to become an increasingly material contributor to Group performance over the medium term. The Products business experienced more modest order intake in the first quarter, followed by an improvement in the second quarter, providing greater revenue visibility into the second half.

 

During H1 FY26, the Group continued to secure further design wins across both its Products and Systems businesses, with a projected lifetime value (LTV) of approximately £129m. These design wins enhance medium-term revenue visibility and underpin the Group's future growth pipeline.

 

The Group is also seeing increased conversion of earlier design wins, secured three to four years ago, into production orders, supporting the transition of pipeline opportunities into revenue.

 

To support anticipated demand, the Group's Colchester manufacturing expansion is progressing to plan, with output capacity expected to approximately double from Q3 2026.

 

The Group has continued to proactively manage industry-wide supply chain challenges, including securing supplier commitments for forecast DRAM requirements through 2026 and into 2027. In addition, following accelerated end-of-life announcements affecting certain Intel processor families, the Group has worked closely with customers and suppliers to secure future programme requirements through appropriate forward procurement arrangements.

 

The Company has entered H2 FY26 with good momentum, demonstrated by the $9.4m contract win announced post period end. Combined with a healthy backlog and pipeline and the expected conversion of design wins into production in H2, the Board believes that the Company is well positioned to at least deliver full year results for 2026 in line with current market expectations*.

 

Miles Adcock, CEO of Concurrent Technologies, commented: "Delivering record first-half results reflects the continued strength of demand across our key markets and the successful execution of our growth strategy across both Products and Systems. The increasing conversion of earlier design wins into production orders, as anticipated, is particularly encouraging, alongside continued new programme wins, which together are enhancing the visibility and quality of future revenues across the Group.

 

"Underlying demand remains strong, and alongside a solid order book, the Group is well positioned for the second half of the year and beyond."

 

*In so far as the Board is aware, consensus market expectations for FY26 are revenues of £53m and profit before tax of £8m.

 

The person responsible for the release of this announcement is Miles Adcock, CEO of Concurrent.

 

Enquiries:

 

Concurrent Technologies Plc Miles Adcock - CEO

Kim Garrod - CFO

 

 

+44 (0)1206 752626

 

Alma Strategic Communications Hannah Campbell / Josh Royston / Will Merison

 

+44 (0)20 3405 0205

 

Investec Bank plc (Financial Adviser, Nominated Adviser and Corporate Broker) Nick Prowting / Virginia Bull / Arnav Kapoor / Tommy Jackson

+44 (0)20 7597 5970

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.concurrent.tech.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRTMTTMTIBBFF
Date   Source Headline
5th Jan 20109:31 amRNSTrading Update
24th Dec 20099:15 amRNSTotal Voting Rights
2nd Dec 200912:00 pmRNSTransaction in Own Shares
30th Nov 20091:57 pmRNSTotal Voting Rights
9th Nov 20095:30 pmRNSTransaction in Own Shares
29th Oct 20099:07 amRNSProduct Launch
26th Oct 200911:21 amRNSHolding(s) in Company
22nd Oct 20092:48 pmRNSHolding(s) in Company
15th Oct 20097:00 amRNSProduct Launch
28th Sep 20093:39 pmRNSHolding(s) in Company
28th Sep 20091:14 pmRNSHolding(s) in Company
3rd Sep 20097:00 amRNSHalf Yearly Report
2nd Sep 20097:00 amRNSProduct Launch
1st Sep 200912:02 pmRNSTotal Voting Rights
28th Aug 20092:39 pmRNSHolding(s) in Company
28th Aug 20092:38 pmPRNNotice of Results
19th Aug 20098:48 amPRNProduct Launch
23rd Jul 20099:59 amPRNProduct Launch
1st Jul 20092:44 pmRNSTreasury Shares
30th Jun 20095:04 pmRNSTotal Voting Rights
30th Jun 20093:15 pmRNSDirector/PDMR Shareholding
22nd Jun 20093:27 pmRNSTransaction in Own Shares
4th Jun 20094:11 pmRNSHolding(s) in Company
2nd Jun 20093:06 pmRNSHolding(s) in Company
20th May 20094:35 pmRNSDistribution of Annual Report & Accounts
20th May 20093:09 pmRNSHolding(s) in Company (Replacement)
20th May 20092:44 pmRNSHolding(s) in Company
18th May 20094:10 pmRNSHolding(s) in Company
5th May 20094:11 pmRNSHolding(s) in Company
27th Apr 20097:00 amPRNFinal Results
20th Apr 20092:13 pmRNSNotice of Results
16th Apr 20094:57 pmRNSHolding(s) in Company
2nd Apr 20097:00 amPRNProduct Launch
9th Mar 20092:32 pmRNSTotal Voting Rights
4th Feb 20097:00 amRNSTransaction in Own Shares
6th Jan 200912:12 pmPRNTrading Statement
5th Dec 20084:02 pmPRNProduct Launch
4th Dec 20084:00 pmPRNDirector/PDMR Shareholding
28th Nov 200810:51 amRNSTotal Voting Rights
21st Nov 20088:00 amRNSTransaction in Own Shares
10th Nov 200810:26 amPRNProduct Launch
7th Nov 20082:46 pmRNSTransaction in Own Shares
4th Nov 20088:00 amRNSTransaction in Own Shares
31st Oct 200812:05 pmRNSTotal Voting Rights
24th Oct 20087:00 amRNSTreasury Shares
22nd Oct 20087:00 amRNSTreasury Shares
21st Oct 20083:14 pmRNSDirector/PDMR Shareholding
21st Oct 200812:27 pmRNSDirector/PDMR Shareholding
17th Oct 20081:43 pmRNSTreasury Shares
10th Oct 20081:16 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.